Home/Roundup/Roundup Litigation 2026: The $7.25 Billion Turning Point

Roundup Litigation 2026: The $7.25 Billion Turning Point

Roundup Litigation 2026: The $7.25 Billion Turning Point

Roundup Litigation 2026: The $7.25 Billion Turning Point

If you’ve been following the saga of Bayer (Monsanto) and its weedkiller, Roundup, you know it’s been a decade of blockbuster jury awards followed by years of legal stalemates. But as of March 2026, the tide is shifting. Between a massive new settlement proposal and a high-stakes showdown at the U.S. Supreme Court, we are entering what might be the final chapter of this historic litigation.

Here is everything you need to know about the current state of the Roundup lawsuits.


1. The Big News: The $7.25 Billion Settlement

In February 2026, Bayer announced a massive $7.25 billion class action settlement intended to resolve nearly all current and future claims involving non-Hodgkin lymphoma (NHL).

On March 4, 2026, a Missouri judge granted preliminary approval to this deal. While it’s not a "done deal" yet, it marks the most significant step toward ending the litigation since the original $11 billion settlement in 2020.

Key Terms of the Proposed Settlement:

  • Who is covered: Individuals exposed to Roundup who were diagnosed with NHL before February 17, 2026, and those diagnosed within 16 years after final approval.

  • Payouts: Estimated individual awards range from $6,000 to $165,000, depending on factors like age, severity of illness, and level of exposure.

  • Timeline: Payments would be distributed over a period of up to 21 years.

  • The "Opt-Out" Clause: If you are a part of this class, you have until June 4, 2026, to "opt out" if you prefer to take your chances with an individual trial.


2. The Supreme Court: "Preemption" Is the Word

While Bayer is trying to settle, they are also playing hardball in the highest court in the land. The U.S. Supreme Court has agreed to hear the case of Monsanto Co. v. Durnell, with oral arguments scheduled for April 27, 2026.

The core issue is federal preemption. Bayer argues that because the EPA approved Roundup’s label without a cancer warning, state-level "failure to warn" lawsuits should be legally barred.

Why this matters: If the Supreme Court rules in Bayer’s favor this June, it could effectively kill thousands of pending lawsuits overnight. It would mean federal law (FIFRA) trumps state law, shielding Bayer from liability regarding its product labeling.


3. Recent Verdicts: A Rollercoaster for Victims

Despite the settlement talks, trials have continued to produce eye-popping numbers. In 2025 and early 2026, we saw:

  • $2.1 Billion awarded to a Georgia man (later settled confidentially for a lower amount).

  • $1.56 Billion awarded by a Missouri jury to three separate plaintiffs.

  • $332 Million awarded in a San Diego trial.

These massive "nuclear" verdicts are exactly what Bayer is trying to avoid by pushing the $7.25 billion settlement. For many plaintiffs, the choice is now between a guaranteed (but smaller) settlement check or a high-risk, high-reward trial that could be nullified by the Supreme Court.


4. What Should You Do Now?

If you or a loved one has been diagnosed with non-Hodgkin lymphoma after using Roundup, the clock is ticking. Contact us today.

Discussion

Loading comments...